Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|March 23, 2011

Almac to Demo Joint Service Offerings

Recently, Almac has enhanced its offerings by forming an exclusive integrated trial management alliance with Exco InTouch, a firm specializing in patient recruitment, retention, compliance, and ePRO services.The joint Almac-Exco InTouch service offering aims to enhance patient retention and compliance through the use of multiple technologies, such as SMS text messages and emails. The technology reminds patients to complete key elements of their required study obligations, such as taking medication, attending appointments, fasting prior to laboratory testing, filling out diaries, and others, while also collecting reasons for non-compliance. Working with sponsors on clinical trials, Almac will develop study-specific patient retention and compliance programs that will begin immediately upon randomization into the trial and remain in effect until the trial is completed.

Almac announced that the new joint services will be demonstrated at the DIA’s 23nd Annual EuroMeeting located in Berlin, Germany, March 27-28 and at the Partnerships in Clinical Trials Conference in Phoenix, Arizona, March 30 – April 1. In addition to featuring its the new integration with Exco InTouch, Almac will be demonstrating its IXRS® (Interactive Voice and Web Response) services and Almac’s Interactive Reporting solution, two services that were launched in 2010.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.